Immunocompromised patients and COVID infections: Who’s at risk?

Early in the pandemic, clinicians noticed that certain immunocompromised patients were experiencing persistent SARS-CoV-2 infections, some lasting weeks to months at a time.

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart